関連する実験動画
Updated: May 31, 2026
09:10
DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
Published on: July 22, 2022
休息中のNMDA受容体阻害は,急速な行動抗うつ薬反応を誘発する
Anita E Autry1, Megumi Adachi, Elena Nosyreva
1Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9111, USA.
Nature
|June 17, 2011
まとめ
ケタミンは,N-メチル-D-アスパルテート受容体 (NMDARs) を標的にすることで,うつ病を迅速に緩和します. この迅速に作用する抗うつ剤の効果は,脳由来の神経栄養因子合成を伴うため,新たな治療法を提供している.
科学分野:
- 神経科学は神経科学である.
- 薬理学 薬理学とは
- 分子生物学は分子生物学である.
背景:
- メジャーうつ病 (MDD) には迅速な治療法がなく,従来の抗うつ剤は有効性を示すのに数週間かかります.
- ケタミンは,N-メチル-D-アスパルテート受容体 (NMDAR) アナゴニストであり,迅速に作用する抗うつ剤効果を示しているが,そのメカニズムは不明である.
- 特に自殺のリスクのある患者にとって,より迅速な抗うつ薬療法の緊急の必要性は,ケタミンの作用を理解することの重要性を強調しています.
研究 の 目的:
- ケタミンの迅速な抗うつ効果の基礎となる細胞メカニズムを解明する.
- ケタミンの抗うつ剤のような作用における脳由来神経栄養因子 (BDNF) の役割を調査する.
- 新型抗うつ剤の開発のためのタンパク質合成調節を標的とする可能性を調査する.
主な方法:
- ネズミのモデルにケタミンや他のNMDARアンタゴニストを投与し,行動的な抗うつ剤のような効果を評価した.
- NMDAR阻害がエウカリオット延長因子2 (eEF2) キナーゼ活性とBDNF合成に与える影響を調査した.
- 抗うつ剤のような効果を評価するためにeEF2キナーゼの阻害剤を使用した.
主要な成果:
- ケタミンとNMDARの抗生物質は,マウスで急速な行動抗うつ剤のような効果を生み出しました.
- ケタミンの効果は,脳由来神経栄養因子 (BDNF) の急速な合成に依存していた.
- ケタミンはeEF2キナーゼを無効化し,eEF2のリン酸化を減らし,BDNF翻訳を増加させます.
結論:
- ケタミンの抗うつ作用は,NMDARブロックによって媒介され,BDNF合成につながります.
- eEF2キナーゼの抑制は,ケタミンの迅速な作用の抗うつ剤のような効果を模倣する.
- 自発的な神経伝達によるタンパク質合成の調節は,迅速に作用する抗うつ剤の有望な治療目標です.
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...